MORITA Tominori | Department of Biology, New Drug Research Laboratories, Kanebo Ltd.
スポンサーリンク
概要
関連著者
-
MORITA Tominori
Department of Biology, New Drug Research Laboratories, Kanebo Ltd.
-
Satoh Keisuke
Department Of Pathophysiological And Therapeutic Science Division Of Molecular Pharmacology Tottori
-
TAIRA Norio
Department o f Pharmacology, Tohoku University, School of Medicine
-
MURATA Yosuke
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Osaka University
-
Murata Yosuke
Department Of Biology New Drug Research Laboratories Kanebo Ltd.
-
Iwamoto Takahiro
Department Of Medical Engineering And Cardiology Institute Of Development Aging And Cancer Tohoku Un
-
NAKAJIMA Fumio
Departments of Urology, National Defense Medical College
-
Nakajima Fumio
Department Of Biology New Drug Research Laboratories Kanebo Ltd.
-
Harada K
Roman Industries Co. Ltd.
-
MORITA Tomonari
Department of Pharmaceutics, Kyoritsu University of Pharmacy
-
Morita Tomonari
Department Of Pharmaceutics Kyoritsu University Of Pharmacy
-
Maruo Joji
New Drug Discovery Research Laboratory Kanebo Ltd.
-
Ito Keizo
Department Of Hygiene And Preventive Medicine School Of Medicine Hokkaido University
-
HARADA Kengo
Department of Biology, New Drug Research Laboratories, Kanebo Ltd.
-
MARUO Joji
Department of Biology, New Drug Research Laboratories, Kanebo Ltd.
-
Sukamoto Takayuki
Department Of Pharmacology Jichi Medical School
-
Ito Keizo
Department of Pharmacology, New Drug Research Laboratories, Kanebo Ltd.
-
MORITA Tominori
Department of Pharmacology, Tohoku University School of Medicine
-
Iwamoto Takahiro
Department of Pharmacology, New Drug Research Laboratories, Kanebo Ltd.
著作論文
- Non-selective Effects of Amiloride and Its Analogues on Ion Transport Systems and Their Cytotoxicities in Cardiac Myocytes
- Comparison of the cardiovascular and biochemical profiles of a new positive inotropic drug, AR-L 115 BS, with those of theophylline.
- Effects of KB-2796, a New Diphenylpiperazine Calcium Antagonist, on Renal Hemodynamics and Urine Formation in Anesthetized Dogs.
- Improvement of cardiac performance by AR-L 115 BS, a new cardiotonic drug, in the experimental failing dog heart.